Cargando…

Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy

Cystoisospora belli is an intestinal Apicomplexan parasite associated with diarrheal illness and disseminated infections in humans, mainly immunocompromised individuals such as those living with the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). An irregular adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Galván-Díaz, Ana Luz, Alzate, Juan Carlos, Villegas, Esteban, Giraldo, Sofía, Botero, Jorge, García-Montoya, Gisela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318389/
https://www.ncbi.nlm.nih.gov/pubmed/34111337
http://dx.doi.org/10.7705/biomedica.5932
_version_ 1783730232138661888
author Galván-Díaz, Ana Luz
Alzate, Juan Carlos
Villegas, Esteban
Giraldo, Sofía
Botero, Jorge
García-Montoya, Gisela
author_facet Galván-Díaz, Ana Luz
Alzate, Juan Carlos
Villegas, Esteban
Giraldo, Sofía
Botero, Jorge
García-Montoya, Gisela
author_sort Galván-Díaz, Ana Luz
collection PubMed
description Cystoisospora belli is an intestinal Apicomplexan parasite associated with diarrheal illness and disseminated infections in humans, mainly immunocompromised individuals such as those living with the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). An irregular administration of highly active antiretroviral therapy (HAART) in HIV patients may increase the risk of opportunistic infections like cystoisosporiasis. We describe here a case of C. belli infection in a Colombian HIV patient with chronic gastrointestinal syndrome and poor adherence to HAART. His clinical and parasitological cure was achieved with trimethoprim-sulfamethoxazole treatment. Although a reduction in the number of C. belli cases has been observed since the use of HAART, this parasite still has to be considered as a differential diagnosis of diarrheal disease in HIV/AIDS patients. Effective interventions enhancing adherence to HAART should be included in HIV patient care programs.
format Online
Article
Text
id pubmed-8318389
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Instituto Nacional de Salud
record_format MEDLINE/PubMed
spelling pubmed-83183892021-07-29 Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy Galván-Díaz, Ana Luz Alzate, Juan Carlos Villegas, Esteban Giraldo, Sofía Botero, Jorge García-Montoya, Gisela Biomedica Case Report Cystoisospora belli is an intestinal Apicomplexan parasite associated with diarrheal illness and disseminated infections in humans, mainly immunocompromised individuals such as those living with the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). An irregular administration of highly active antiretroviral therapy (HAART) in HIV patients may increase the risk of opportunistic infections like cystoisosporiasis. We describe here a case of C. belli infection in a Colombian HIV patient with chronic gastrointestinal syndrome and poor adherence to HAART. His clinical and parasitological cure was achieved with trimethoprim-sulfamethoxazole treatment. Although a reduction in the number of C. belli cases has been observed since the use of HAART, this parasite still has to be considered as a differential diagnosis of diarrheal disease in HIV/AIDS patients. Effective interventions enhancing adherence to HAART should be included in HIV patient care programs. Instituto Nacional de Salud 2021-05-31 /pmc/articles/PMC8318389/ /pubmed/34111337 http://dx.doi.org/10.7705/biomedica.5932 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Case Report
Galván-Díaz, Ana Luz
Alzate, Juan Carlos
Villegas, Esteban
Giraldo, Sofía
Botero, Jorge
García-Montoya, Gisela
Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title_full Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title_fullStr Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title_full_unstemmed Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title_short Chronic Cystoisospora belli infection in a Colombian patient living with HIV and poor adherence to highly active antiretroviral therapy
title_sort chronic cystoisospora belli infection in a colombian patient living with hiv and poor adherence to highly active antiretroviral therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318389/
https://www.ncbi.nlm.nih.gov/pubmed/34111337
http://dx.doi.org/10.7705/biomedica.5932
work_keys_str_mv AT galvandiazanaluz chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy
AT alzatejuancarlos chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy
AT villegasesteban chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy
AT giraldosofia chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy
AT boterojorge chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy
AT garciamontoyagisela chroniccystoisosporabelliinfectioninacolombianpatientlivingwithhivandpooradherencetohighlyactiveantiretroviraltherapy